Description
100 box (MOQ)
1. Hypertension.
2. Angina.
After oral administration of therapeutic doses of levamlodipine besylate tablets, absorption produces peak plasma concentrations between 6 and 12 hours.
Absolute bioavailability has been estimated to be between 64 and 90%. The apparent volume of distribution is 21L/kg, and with a terminal elimination half-life of about 30-50 hours.
Steady-state plasma levels of amlodipine are reached after 7 to 8 days of consecutive daily dosing. Amlodipine besylate is extensively converted to inactive metabolites via hepatic metabolism with 10% of the parent compound and 60% of the metabolites excreted in the urine.
Approximately 97.5% of the circulating drug is bound to plasma proteins.


Reviews
There are no reviews yet.